Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that changes in eyelashes and eyelid skin can indicate various local and systemic diseases.

Hair follicles offer promising targets for delivering drugs to treat hair and skin conditions.

Two teenage brothers had a rare, treatment-resistant form of female-pattern hair loss with unusual scalp changes.

Skin stem cells remember past inflammation, helping them respond better to future injuries and possibly aiding in treating skin issues.

Newborn screening and gene therapy are expected to improve outcomes for Omenn syndrome patients.

Chemotherapy and radiotherapy can cause skin side effects like rashes, hair loss, and nail changes, which are usually managed with conservative treatments.

Patients with Systemic Sclerosis have much higher levels of GDF-15, which could help predict organ involvement and guide treatment.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

Chemotherapy and bone marrow transplant can cause permanent hair loss.

Valproic Acid could potentially be used to treat immune-related conditions due to its ability to modify immune cell functions.

Photodynamic therapy is the preferred treatment for skin precancer due to its effectiveness and safety.

Using systemic drugs as creams for skin conditions shows promise, but more research is needed to confirm their effectiveness and safety.

Experts discussed treatments for skin conditions in children, emphasizing hydration, cautious medication use, and early intervention for infections.

Prednisone has risks for lupus patients, isotretinoin is safe for mental health, transplant patients risk skin cancer, and various treatments are effective for specific skin conditions.

Hair usually grows back 1-3 months after treatment for anagen effluvium, and children with Loose Anagen Hair Syndrome often improve by adolescence.

Certain diets can affect skin conditions, but more research is needed to understand these relationships fully.

Cicatricial alopecia, a permanent hair loss condition, is mainly caused by damage to specific hair follicle stem cells and abnormal immune responses, with gene regulator PPAR-y and lipid metabolism disorders playing significant roles.

Some cancer and immune system drugs can cause serious side effects, including heart, lung, nerve, and organ damage, which need careful monitoring and management.

Thymus transplantation successfully restored immune function in infants with FOXN1 deficiency.

The document concludes that surgery is a preferred treatment for cicatricial alopecia, with the method chosen based on individual factors and may require multiple sessions and careful postoperative care.

MSC-Exos can aid organ development and offer therapeutic benefits for various conditions.

The book details skin conditions in older adults, their link to mental health, cancer treatment importance, hair loss remedies, and managing autoimmune and itchy skin.

Chemotherapy and cytokine therapy can cause various skin reactions, including hair loss and hypersensitivity.

Spironolactone may help improve symptoms and tear quality in dry eye disease.

Fibroblasts are crucial for tissue repair and inflammation, and understanding them can help treat fibrotic diseases.

Mesenchymal stem cells show promise for treating various skin conditions and may help regenerate hair.

Proteomics combined with other technologies can lead to a better understanding of skin diseases.

Different types of cell death affect skin health and inflammation, and understanding them could improve treatments for skin diseases.

Platelet-rich plasma (PRP) may improve healing in chronic wounds and vitiligo and promote hair regrowth, but more research is needed.

Mesenchymal stromal cell therapies show promise for treating various diseases but need more research and standardization.